1 |
Badrey MG, Gomha SM, Abdelmonsef AH, El-reedy AAM. Syntheses and Molecular Docking Analysis of Some New Thiazole and Thiazine Derivatives as Three Armed Molecules with a Triazine Ring as a Core Component: A Search for anti-Obesity Agents. Polycyclic Aromatic Compounds 2023. [DOI: 10.1080/10406638.2023.2173617] [Reference Citation Analysis]
|
2 |
Noser AA, Abdelmonsef AH, Salem MM. Design, synthesis and molecular docking of novel substituted azepines as inhibitors of PI3K/Akt/TSC2/mTOR signaling pathway in colorectal carcinoma. Bioorg Chem 2023;131:106299. [PMID: 36493622 DOI: 10.1016/j.bioorg.2022.106299] [Reference Citation Analysis]
|
3 |
Abdelmonsef AH, El-saghier AM, Kadry AM. Ultrasound-assisted green synthesis of triazole-based azomethine/thiazolidin-4-one hybrid inhibitors for cancer therapy through targeting dysregulation signatures of some Rab proteins. Green Chemistry Letters and Reviews 2023;16. [DOI: 10.1080/17518253.2022.2150394] [Reference Citation Analysis]
|
4 |
Desai NC, Monapara JD, Jethawa AM, Pandit U. Contemporary development in the synthesis and biological applications of pyridine-based heterocyclic motifs. Recent Developments in the Synthesis and Applications of Pyridines 2023. [DOI: 10.1016/b978-0-323-91221-1.00007-5] [Reference Citation Analysis]
|
5 |
Priya, Jaswal S, Gupta GD, Verma SK. A Comprehension on Synthetic Strategies of Aurora kinase A and B Inhibitors. Journal of Molecular Structure 2023. [DOI: 10.1016/j.molstruc.2023.134935] [Reference Citation Analysis]
|
6 |
Abdelmonsef AH, Omar M, Rashdan HRM, Taha MM, Abobakr AM. Design, synthetic approach, in silico molecular docking and antibacterial activity of quinazolin-2,4-dione hybrids bearing bioactive scaffolds. RSC Adv 2022;13:292-308. [PMID: 36605637 DOI: 10.1039/d2ra06527d] [Reference Citation Analysis]
|
7 |
Rashdan HRM, Abdelmonsef AH. Towards Covid-19 TMPRSS2 enzyme inhibitors and antimicrobial agents: Synthesis, antimicrobial potency, molecular docking, and drug-likeness prediction of thiadiazole-triazole hybrids. J Mol Struct 2022;1268:133659. [PMID: 35818577 DOI: 10.1016/j.molstruc.2022.133659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
8 |
H. Narasimhamurthy K, Kallesha N, D. Mohan C, S. Rangappa K. Anticancer Functions of Pyridine Heterocycles. Cytotoxicity [Working Title] 2022. [DOI: 10.5772/intechopen.106156] [Reference Citation Analysis]
|
9 |
Noser AA, Shehadi IA, Abdelmonsef AH, Salem MM. Newly Synthesized Pyrazolinone Chalcones as Anticancer Agents via Inhibiting the PI3K/Akt/ERK1/2 Signaling Pathway. ACS Omega 2022;7:25265-77. [DOI: 10.1021/acsomega.2c02181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
10 |
Becerra D, Abonia R, Castillo J. Recent Applications of the Multicomponent Synthesis for Bioactive Pyrazole Derivatives. Molecules 2022;27:4723. [DOI: 10.3390/molecules27154723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
11 |
Rashdan HRM, Abdelmonsef AH. In silico study to identify novel potential thiadiazole-based molecules as anti-Covid-19 candidates by hierarchical virtual screening and molecular dynamics simulations. Struct Chem 2022;:1-13. [PMID: 35729938 DOI: 10.1007/s11224-022-01985-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
12 |
Rashdan HRM, Abdelrahman MT, Shehadi IA, El-Tanany SS, Hemdan BA. Novel Thiadiazole-Based Molecules as Promising Inhibitors of Black Fungi and Pathogenic Bacteria: In Vitro Antimicrobial Evaluation and Molecular Docking Studies. Molecules 2022;27. [PMID: 35684551 DOI: 10.3390/molecules27113613] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
13 |
Sabt A, Abdelrahman MT, Abdelraof M, Rashdan HRM. Investigation of Novel Mucorales Fungal Inhibitors: Synthesis, In‐Silico Study and Anti‐Fungal Potency of Novel Class of Coumarin‐6‐Sulfonamides‐Thiazole and Thiadiazole Hybrids. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202200691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
14 |
Rashdan HRM, Shehadi IA, Chen T. Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer Treatment. Heteroatom Chemistry 2022;2022:1-16. [DOI: 10.1155/2022/5349279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
15 |
Abo-bakr AM, Alsoghier HM, Abdelmonsef AH. Molecular docking, modeling, semiempirical calculations studies and in vitro evaluation of new synthesized pyrimidin-imide derivatives. Journal of Molecular Structure 2022;1249:131548. [DOI: 10.1016/j.molstruc.2021.131548] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
16 |
Chandrasekaran R, Murugavel S, Silambarasan T. Synthesis, quantum chemical, and molecular modeling investigations of 1,2,3‐triazole fused dicarboxylate bioorganic derivative as angiotensin‐converting enzyme inhibitor. J Chinese Chemical Soc. [DOI: 10.1002/jccs.202100482] [Reference Citation Analysis]
|
17 |
Hassan EA, Shehadi IA, Elmaghraby AM, Mostafa HM, Zayed SE, Abdelmonsef AH. Synthesis, Molecular Docking Analysis and in Vitro Biological Evaluation of Some New Heterocyclic Scaffolds-Based Indole Moiety as Possible Antimicrobial Agents. Front Mol Biosci 2022;8:775013. [DOI: 10.3389/fmolb.2021.775013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
18 |
Hussein AHM, El-adasy AA, El-saghier AM, Olish M, Abdelmonsef AH. Synthesis, characterization, in silico molecular docking, and antibacterial activities of some new nitrogen-heterocyclic analogues based on a p -phenolic unit. RSC Adv 2022;12:12607-21. [DOI: 10.1039/d2ra01794f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
19 |
Rashdan HRM, Abdelmonsef AH, Abou-Krisha MM, Yousef TA. Synthesis, Identification, Computer-Aided Docking Studies, and ADMET Prediction of Novel Benzimidazo-1,2,3-triazole Based Molecules as Potential Antimicrobial Agents. Molecules 2021;26:7119. [PMID: 34885701 DOI: 10.3390/molecules26237119] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
20 |
Abdelmonsef AH, Abdelhakeem MA, Mosallam AM, Temairk H, El‐naggar M, Okasha H, Rashdan HRM. A search for antiinflammatory therapies: Synthesis, in silico investigation of the mode of action, and in vitro analyses of new quinazolin‐2,4‐dione derivatives targeting phosphodiesterase‐4 enzyme. J Heterocyclic Chem. [DOI: 10.1002/jhet.4395] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
21 |
Noser AA, Abdelmonsef AH, El-Naggar M, Salem MM. New Amino Acid Schiff Bases as Anticancer Agents via Potential Mitochondrial Complex I-Associated Hexokinase Inhibition and Targeting AMP-Protein Kinases/mTOR Signaling Pathway. Molecules 2021;26:5332. [PMID: 34500765 DOI: 10.3390/molecules26175332] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
22 |
Mahmoud A, Afifi MM, El Shenawy F, Salem W, Elesawy BH. Syzygium aromaticum Extracts as a Potential Antibacterial Inhibitors against Clinical Isolates of Acinetobacter baumannii: An In-Silico-Supported In-Vitro Study. Antibiotics (Basel) 2021;10:1062. [PMID: 34572644 DOI: 10.3390/antibiotics10091062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
23 |
Rashdan HRM, Shehadi IA, Abdelrahman MT, Hemdan BA. Antibacterial Activities and Molecular Docking of Novel Sulfone Biscompound Containing Bioactive 1,2,3-Triazole Moiety. Molecules 2021;26:4817. [PMID: 34443405 DOI: 10.3390/molecules26164817] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
24 |
Pradhan T, Gupta O, Singh G, Monga V. Aurora kinase inhibitors as potential anticancer agents: Recent advances. Eur J Med Chem 2021;221:113495. [PMID: 34020340 DOI: 10.1016/j.ejmech.2021.113495] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|